https://www.selleckchem.com/products/ml390.html
onnectivity from the right anterior insula to the left dorsolateral prefrontal cortex. Both treatment targets benefit from the level of MRI guidance, but only TBS is provided with precision targeting based on functional brain connectivity. Recruitment began in January 2019 and is ongoing. Data collection is expected to continue until January 2023. This trial will determine the impact of precision MRI guidance on rTMS treatment and assess the neural mechanisms underlying this treatment in treatment-resistant depressed patients. ISRCTN Regi
Like
Comment
Share
